𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dramatic response to single-agent rituximab in a patient with intravascular lymphoma

✍ Scribed by Nandagopal Vrindavanam; Mehdi Hamadani; Barbara Steele; Farrukh Awan; Saul Suster; Don M. Benson Jr.

Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
356 KB
Volume
82
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Response of myasthenia gravis to rituxim
Response of myasthenia gravis to rituximab in a patient with non-Hodgkin lymphoma
✍ Ajeet Gajra; Neerja Vajpayee; Sara J. Grethlein πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 43 KB πŸ‘ 2 views

## Abstract Myasthenia gravis is a B‐cell‐mediated autoimmune neuromuscular disorder characterized by weakness and fatigability of skeletal muscles. The underlying defect is an autoantibody‐mediated attack on the acetylcholine receptors (AchRs) at the neuromuscular junction. Rituximab is a genetica

Disseminated intravascular coagulation a
Disseminated intravascular coagulation and excessive fibrinolysis in a patient with metastatic prostate cancer. Response to epsilon-aminocaproic acid
✍ Dennis L. Cooper; Alan B. Sander; Lynn D. Wilson; Thomas P. Duffy πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 359 KB πŸ‘ 2 views

## Background: Disseminated intravascular coagulation (dic) and primary fibrinolysis have both been reported in association with prostate carcinoma. the correct diagnosis of the coagulopathy can be difficult and the appropriate management controversial. ## Methods: A case is presented of a man in

Single agent versus combination chemothe
Single agent versus combination chemotherapy in patients with advanced nonsmall cell lung carcinoma : A meta-analysis of response, toxicity, and survival
✍ Rogerio C. Lilenbaum; Patricia Langenberg; Kay Dickersin πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 182 KB πŸ‘ 2 views

## Background: This meta-analysis was conducted to compare the effects of single agent versus combination chemotherapy on response rate, toxicity, and survival of patients with advanced nonsmall cell lung carcinoma (nsclc). ## Methods: The authors reviewed randomized clinical trials published in